Ramamoorthy Nagasubramanian
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (3)
PURPOSE The objective was to identify factors associated with self-reported symptom burden measured using Symptom Screening in Pediatrics Tool (SSPedi) in pediatric patients with cancer. METHODS This was a secondary analysis of a cluster randomized trial enrolling pediatric patients newly diagnosed with cancer. Twenty sites were randomized to routine symptom screening versus usual care. Intervention included thrice-weekly symptom screening with SSPedi, delivery of severely bothersome scores to health care teams, and implementation of locally adapted symptom management care pathways. Primary outcome was total SSPedi scores, 0 (no bothersome symptoms) to 60 (worst bothersome symptoms), obtained at baseline, week four, and week eight in 430 patients (n = 217 intervention and n = 213 usual care). We created a mixed linear regression model evaluating design (including time point), patient/guardian, and site characteristics for their associations with symptom burden after controlling for treatment assignment. RESULTS SSPedi scores were significantly lower at weeks 4 and 8 compared with baseline ( P < .0001 overall), and at intervention versus control sites ( P < .0001). In the full model, males (estimate, –3.3 [95% CI, –4.6 to –2.0]; P < .0001) and sites with higher physician staffing ratios (each physician full-time equivalent per 100 new diagnoses estimate –0.20 [95% CI, –0.5 to 0.0]; P = .024) had significantly lower total SSPedi scores. CONCLUSION Total symptom burden was reduced by time, intervention (symptom screening and care pathways), and greater physician staffing ratio. Females had higher symptom burden. These data may inform programmatic implementation of routine symptom screening in pediatric patients with cancer.
Year:
2025
PURPOSE Ten pediatric cancer treatment sites previously implemented site-specific symptom management care pathways for 15 symptoms, which were based upon clinical practice guidelines (CPGs). The primary objective of this analysis was to describe the prevalence of care pathway– and CPG-consistent care for symptom management. The secondary objective was to identify factors associated with care pathway–consistent care. METHODS Participants were patients age 8-18 years diagnosed with cancer within the previous 4 weeks. We identified any intervention to manage each of 15 symptoms during a 3-day period 8 weeks after enrollment. We determined whether the intervention appeared in that site's care pathway and whether it was recommended in the CPG. We determined whether type of symptom (observable v nonobservable) or patient characteristics were associated with care pathway–consistent care. RESULTS Two hundred twenty participants were analyzed. The prevalence of care pathway–consistent care for each symptom ranged from 0% (problems thinking, body or face changes, and diarrhea) to 52.3% (throwing up) and was <27% for 14 of 15 symptoms. Similarly, the prevalence of CPG-consistent care was <50% across all symptoms. Participants received significantly more care pathway–consistent interventions for observable symptoms compared with nonobservable symptoms (difference 30% [95% CI, 3 to 54]). Factors associated with receipt of at least one care pathway–consistent intervention were age group, race, ethnicity, and cancer type. CONCLUSION Care pathway– and CPG-consistent care were surprisingly uncommon. Care pathway–consistent interventions were more common for observable than nonobservable symptoms and were associated with patient characteristics. Future work should identify approaches to improve care pathway–consistent care delivery.
Year:
2025
Introduction Objective was to describe the association between baseline characteristics and the number of Symptom Screening in Pediatrics Tool (SSPedi) assessments completed over an 8‐week period. Methods This was a sub‐analysis of a cluster randomized controlled trial among 10 sites that were randomized to the intervention group. Participants were English‐ or Spanish‐speaking pediatric patients 8–18 years of age newly diagnosed with cancer. Participants were prompted to complete SSPedi three times weekly for 8 weeks. The outcome was the number of SSPedi assessments completed during the 8‐week period. Factors associated with the number of assessments were determined using mixed effects Poisson regression. Results At the 10 intervention sites, 216 patients were included in the analysis. Among these participants, 129 (59.7%) were male, 112 (51.9%) were white, and 83 (38.4%) were Hispanic. The number of SSPedi assessments was significantly higher for participants 11–14 years (rate ratio (RR) 1.13, 95% confidence interval (CI) 1.02–1.25) and 15–18 years (RR 1.15, 95% CI 1.04–1.27) compared to 8–10 years. Participants completed more SSPedi assessments if they were Asian compared to white (RR 1.27, 95% CI 1.10–1.46), non‐Hispanic compared to Hispanic (RR 1.15, 95% CI 1.04–1.28) and from families with a household income ≥$60,000 (RR 1.12, 95% CI 1.03–1.21). Participants completed fewer SSPedi assessments if they had solid tumors compared to leukemia (RR 0.91, 95% CI 0.84–0.99). Conclusion Adherence to three‐times weekly SSPedi varied by age, race, ethnicity, cancer diagnosis, and family income. This information may facilitate interventions to support routine symptom screening in clinical practice. Trial Registration: NCT04614662.
Year:
2025
Collaborators (4)
Catherine Aftandilian
Stanford University School of Medicine
Melissa P. Beauchemin
Assistant Professor of Nursing
Columbia University Irving Medical Center
Scott Bradfield
Interim Division Chief
Nemours Children's Health System
Emi Caywood
Director, Transplant and Cellular Therapy
Alfred I DuPont Hospital for Children
Make your next move.
Prepare your application
Review drafts before you send them.